HR
TNDM icon

Howe & Rusling’s Tandem Diabetes Care TNDM Stock Holding History

Howe & Rusling’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-25
Closed -$1K – 883
2019
Q3 		$1K Sell
25
-25
-50% -$1.6K ﹤0.01% 802
2019
Q2 		$3K Hold
50
– – ﹤0.01% 627
2019
Q1 		$3K Hold
50
– – ﹤0.01% 632
2018
Q4 		$2K Hold
50
– – ﹤0.01% 686
2018
Q3 		$2K Hold
50
– – ﹤0.01% 735
2018
Q2 		$1K Buy
+50
New +$615 ﹤0.01% 774

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Howe & Rusling's TNDM Position: Q4 2019 in Review

Howe & Rusling sold out of Tandem Diabetes Care (TNDM) in Q4 2019, closing a stake of 25 shares — an estimated $1K sold.

Howe & Rusling first reported a position in TNDM in Q2 2018 and held it in 6 quarters. The position peaked at $3K in Q2 2019. 284 funds tracked by Wall St. Rank hold TNDM as of Q4 2019.

  • Howe & Rusling reported no remaining Tandem Diabetes Care position as of Q4 2019 after selling out during the quarter.
  • Howe & Rusling sold 25 Tandem Diabetes Care shares in Q4 2019, an estimated $1K.
  • Howe & Rusling first reported a position in Tandem Diabetes Care in Q2 2018 and held it in 6 quarters.
  • Howe & Rusling's Tandem Diabetes Care position peaked at $3K in Q2 2019.
  • 284 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2019.

Based on Howe & Rusling's 13F filing for Q4 2019, filed 5 Feb 2020.